Breaking News

Yesterday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Conference/Events
Raymond James to hold a virtual conference » 04:55
06/23/21
06/23
04:55
06/23/21
04:55
TFX

Teleflex

$404.93 /

+5.265 (+1.32%)

, CBAY

CymaBay

$4.48 /

-0.26 (-5.49%)

, PYPD

PolyPid

$8.91 /

-0.11 (-1.22%)

, AYLA

Ayala Pharmaceuticals

$11.00 /

+0.3 (+2.80%)

, BWAY

Brainsway

$10.30 /

-0.1 (-0.96%)

, ENTA

Enanta

$46.35 /

+0.18 (+0.39%)

, KDMN

Kadmon

$3.83 /

-0.16 (-4.01%)

, ONCS

OncoSec

$3.40 /

+ (+0.00%)

, ATHA

Athira Pharma

$10.33 /

-0.42 (-3.91%)

, QDEL

Quidel

$111.29 /

-0.5 (-0.45%)

, CYTK

Cytokinetics

$22.15 /

+0.38 (+1.75%)

, NGM

NGM Biopharmaceuticals

$20.37 /

+0.28 (+1.39%)

, MEDXF

Medexus Pharmaceuticals

$5.69 /

-0.06 (-1.04%)

, FLXN

Flexion

$8.86 /

-0.28 (-3.06%)

, HRMY

Harmony Biosciences

$31.17 /

-0.83 (-2.59%)

Human Health Innovation…

Human Health Innovation Virtual Conference will be held on June 21-23.

ShowHide Related Items >><<
TFX Teleflex
$404.93 /

+5.265 (+1.32%)

QDEL Quidel
$111.29 /

-0.5 (-0.45%)

PYPD PolyPid
$8.91 /

-0.11 (-1.22%)

ONCS OncoSec
$3.40 /

+ (+0.00%)

NGM NGM Biopharmaceuticals
$20.37 /

+0.28 (+1.39%)

MEDXF Medexus Pharmaceuticals
$5.69 /

-0.06 (-1.04%)

KDMN Kadmon
$3.83 /

-0.16 (-4.01%)

HRMY Harmony Biosciences
$31.17 /

-0.83 (-2.59%)

FLXN Flexion
$8.86 /

-0.28 (-3.06%)

ENTA Enanta
$46.35 /

+0.18 (+0.39%)

CYTK Cytokinetics
$22.15 /

+0.38 (+1.75%)

CBAY CymaBay
$4.48 /

-0.26 (-5.49%)

BWAY Brainsway
$10.30 /

-0.1 (-0.96%)

AYLA Ayala Pharmaceuticals
$11.00 /

+0.3 (+2.80%)

ATHA Athira Pharma
$10.33 /

-0.42 (-3.91%)

TFX Teleflex
$404.93 /

+5.265 (+1.32%)

05/18/21 Piper Sandler
Teleflex divestiture should accelerate sales growth, says Piper Sandler
05/10/21 Piper Sandler
Teleflex management surprised by post-earnings selloff, says Piper Sandler
04/30/21 SVB Leerink
Teleflex price target raised to $485 from $475 at SVB Leerink
02/25/21 Piper Sandler
Teleflex price target raised to $465 from $405 at Piper Sandler
CBAY CymaBay
$4.48 /

-0.26 (-5.49%)

06/21/21 Piper Sandler
Piper radar 'locked' on CymaBay EASL poster presentations on June 23
06/14/21 JonesTrading
JonesTrading starts CymaBay with Buy, $8 target on seladelpar potential
06/14/21 JonesTrading
CymaBay initiated with a Buy at JonesTrading
06/09/21 Piper Sandler
CymaBay to have 'impressive' lineup at EASL meeting, says Piper Sandler
PYPD PolyPid
$8.91 /

-0.11 (-1.22%)

11/24/20 Raymond James
Raymond James upgrades PolyPid to Strong Buy after BTD for D-PLEX
11/24/20 Raymond James
PolyPid upgraded to Strong Buy from Outperform at Raymond James
08/10/20 Alliance Global Partners
PolyPid initiated with a Buy at Alliance Global Partners
07/21/20 Raymond James
PolyPid initiated with an Outperform at Raymond James
AYLA Ayala Pharmaceuticals
$11.00 /

+0.3 (+2.80%)

12/07/20
Fly Intel: Top five analyst initiations
12/07/20 Roth Capital
Ayala Pharmaceuticals initiated with a Buy at Roth Capital
12/02/20
Fly Intel: Top five analyst initiations
12/02/20 Noble Capital
Ayala Pharmaceuticals initiated with an Outperform at Noble Capital
BWAY Brainsway
$10.30 /

-0.1 (-0.96%)

04/20/21 Northland
Brainsway initiated with an Outperform at Northland
02/17/21 Raymond James
Brainsway price target raised to $12 from $9 at Raymond James
ENTA Enanta
$46.35 /

+0.18 (+0.39%)

02/09/21 RBC Capital
Enanta price target raised to $53 from $47 at RBC Capital
01/29/21 JPMorgan
Enanta upgraded to Neutral with $55 target at JPMorgan
01/29/21 JPMorgan
Enanta upgraded to Neutral from Underweight at JPMorgan
01/08/21 Piper Sandler
Enanta remains 'significantly undervalued,' says Piper Sandler
KDMN Kadmon
$3.83 /

-0.16 (-4.01%)

06/04/21 Mizuho
Kadmon's KD022 results a positive start for immuno-oncology program, says Mizuho
05/20/21 UBS
Kadmon initiated with a Buy at UBS
03/11/21 Oppenheimer
Kadmon should be bought on weakness from FDA extension, says Oppenheimer
02/10/21 Jefferies
Survey points to 'encouraging' signs for Kadmon's belumosudil, says Jefferies
ONCS OncoSec
$3.40 /

+ (+0.00%)

04/15/21 Alliance Global Partners
OncoSec price target raised to $11 from $6.50 at Alliance Global Partners
03/25/21 Maxim
OncoSec price target raised to $12 from $8 at Maxim
03/08/21
Fly Intel: Top five analyst initiations
03/08/21 BTIG
OncoSec initiated with a Buy at BTIG
ATHA Athira Pharma
$10.33 /

-0.42 (-3.91%)

06/18/21 Jefferies
Athira Pharma's 'unusual situation' to cause some volatility, says Jefferies
06/18/21 Stifel
Athira Pharma CEO leave situation 'impossible to really vet,' says Stifel
06/07/21 JMP Securities
Aducanumab accelerated approval positive for Athira, others, says JMP Securities
06/07/21 Goldman Sachs
Goldman says Biogen approval has positive read to Alector, Athira
QDEL Quidel
$111.29 /

-0.5 (-0.45%)

06/17/21 Craig-Hallum
Quidel price target lowered to $219 from $296 at Craig-Hallum
06/04/21 JPMorgan
Quidel price target lowered to $80 from $90 at JPMorgan
05/07/21 JPMorgan
Quidel price target lowered to $90 from $95 at JPMorgan
04/23/21 JPMorgan
Quidel price target lowered to $95 from $120 at JPMorgan
CYTK Cytokinetics
$22.15 /

+0.38 (+1.75%)

05/11/21 Mizuho
Cytokinetics price target raised to $36 from $26 at Mizuho
03/11/21 Wolfe Research
Cytokinetics initiated with an Outperform at Wolfe Research
02/18/21 Barclays
Cytokinetics initiated with an Overweight at Barclays
01/20/21 H.C. Wainwright
Cytokinetics price target raised to $41 from $22 at H.C. Wainwright
NGM NGM Biopharmaceuticals
$20.37 /

+0.28 (+1.39%)

05/25/21 B. Riley
NGM 'disappointing failure' in NASH a 'clearing event,' says B. Riley
05/25/21 BMO Capital
NGM Biopharmaceuticals price target lowered to $20 from $38 at BMO Capital
05/25/21 Raymond James
Raymond James downgrades two NASH players following NGM data
05/24/21 Piper Sandler
Piper says Madrigal's MAESTRO-NASH outcome not impacted by NGM ALPINE data
MEDXF Medexus Pharmaceuticals
$5.69 /

-0.06 (-1.04%)

06/18/21 Canaccord
Medexus Pharmaceuticals price target lowered to C$9 from C$9.50 at Canaccord
03/03/21 Canaccord
Medexus Pharmaceuticals upgraded to Buy from Hold at Canaccord
02/24/21 Stifel
Medexus Pharmaceuticals price target raised to C$17.50 from C$7.25 at Stifel
FLXN Flexion
$8.86 /

-0.28 (-3.06%)

04/26/21 Credit Suisse
Flexion assumed with an Outperform at Credit Suisse
04/14/21 Raymond James
Flexion price target lowered to $16 from $18 at Raymond James
04/06/21 RBC Capital
Flexion transferred with an Outperform at RBC Capital
08/20/20 Goldman Sachs
Flexion initiated with a Neutral at Goldman Sachs
HRMY Harmony Biosciences
$31.17 /

-0.83 (-2.59%)

03/29/21 Goldman Sachs
Harmony Biosciences upgraded to Buy from Neutral at Goldman Sachs
09/14/20 Jefferies
Harmony Biosciences initiated with a Buy at Jefferies
09/14/20 Piper Sandler
Harmony Biosciences initiated with an Overweight at Piper Sandler
09/13/20 Goldman Sachs
Harmony Biosciences initiated with a Neutral at Goldman Sachs
TFX Teleflex
$404.93 /

+5.265 (+1.32%)

QDEL Quidel
$111.29 /

-0.5 (-0.45%)

PYPD PolyPid
$8.91 /

-0.11 (-1.22%)

NGM NGM Biopharmaceuticals
$20.37 /

+0.28 (+1.39%)

HRMY Harmony Biosciences
$31.17 /

-0.83 (-2.59%)

FLXN Flexion
$8.86 /

-0.28 (-3.06%)

ENTA Enanta
$46.35 /

+0.18 (+0.39%)

CYTK Cytokinetics
$22.15 /

+0.38 (+1.75%)

CBAY CymaBay
$4.48 /

-0.26 (-5.49%)

BWAY Brainsway
$10.30 /

-0.1 (-0.96%)

AYLA Ayala Pharmaceuticals
$11.00 /

+0.3 (+2.80%)

ATHA Athira Pharma
$10.33 /

-0.42 (-3.91%)

  • 23
    Feb
  • 21
    Jan
  • 21
    Jan
  • 06
    Jan
  • 18
    Sep
  • 19
    Aug
  • 17
    Jul
  • 26
    Jun
QDEL Quidel
$111.29 /

-0.5 (-0.45%)

QDEL Quidel
$111.29 /

-0.5 (-0.45%)

ONCS OncoSec
$3.40 /

+ (+0.00%)

NGM NGM Biopharmaceuticals
$20.37 /

+0.28 (+1.39%)

KDMN Kadmon
$3.83 /

-0.16 (-4.01%)

FLXN Flexion
$8.86 /

-0.28 (-3.06%)

ATHA Athira Pharma
$10.33 /

-0.42 (-3.91%)

ONCS OncoSec
$3.40 /

+ (+0.00%)

ATHA Athira Pharma
$10.33 /

-0.42 (-3.91%)

Tuesday
Conference/Events
Raymond James to hold a virtual conference » 04:55
06/22/21
06/22
04:55
06/22/21
04:55
TFX

Teleflex

$399.98 /

+3.115 (+0.78%)

, CBAY

CymaBay

$4.74 /

+0.09 (+1.94%)

, PYPD

PolyPid

$9.02 /

-0.19 (-2.06%)

, AYLA

Ayala Pharmaceuticals

$10.70 /

-0.13 (-1.20%)

, BWAY

Brainsway

$10.40 /

-0.1 (-0.95%)

, ENTA

Enanta

$46.24 /

+0.49 (+1.07%)

, KDMN

Kadmon

$3.99 /

+0.01 (+0.25%)

, ONCS

OncoSec

$3.40 /

-0.025 (-0.73%)

, ATHA

Athira Pharma

$10.75 /

-0.31 (-2.80%)

, QDEL

Quidel

$111.86 /

-1.855 (-1.63%)

, CYTK

Cytokinetics

$21.77 /

+0.46 (+2.16%)

, NGM

NGM Biopharmaceuticals

$20.08 /

-0.26 (-1.28%)

, MEDXF

Medexus Pharmaceuticals

$5.75 /

-0.2922 (-4.84%)

, FLXN

Flexion

$9.14 /

+ (+0.00%)

, HRMY

Harmony Biosciences

$32.00 /

+0.68 (+2.17%)

Human Health Innovation…

Human Health Innovation Virtual Conference will be held on June 21-23.

ShowHide Related Items >><<
TFX Teleflex
$399.98 /

+3.115 (+0.78%)

QDEL Quidel
$111.86 /

-1.855 (-1.63%)

PYPD PolyPid
$9.02 /

-0.19 (-2.06%)

ONCS OncoSec
$3.40 /

-0.025 (-0.73%)

NGM NGM Biopharmaceuticals
$20.08 /

-0.26 (-1.28%)

MEDXF Medexus Pharmaceuticals
$5.75 /

-0.2922 (-4.84%)

KDMN Kadmon
$3.99 /

+0.01 (+0.25%)

HRMY Harmony Biosciences
$32.00 /

+0.68 (+2.17%)

FLXN Flexion
$9.14 /

+ (+0.00%)

ENTA Enanta
$46.24 /

+0.49 (+1.07%)

CYTK Cytokinetics
$21.77 /

+0.46 (+2.16%)

CBAY CymaBay
$4.74 /

+0.09 (+1.94%)

BWAY Brainsway
$10.40 /

-0.1 (-0.95%)

AYLA Ayala Pharmaceuticals
$10.70 /

-0.13 (-1.20%)

ATHA Athira Pharma
$10.75 /

-0.31 (-2.80%)

TFX Teleflex
$399.98 /

+3.115 (+0.78%)

05/18/21 Piper Sandler
Teleflex divestiture should accelerate sales growth, says Piper Sandler
05/10/21 Piper Sandler
Teleflex management surprised by post-earnings selloff, says Piper Sandler
04/30/21 SVB Leerink
Teleflex price target raised to $485 from $475 at SVB Leerink
02/25/21 Piper Sandler
Teleflex price target raised to $465 from $405 at Piper Sandler
CBAY CymaBay
$4.74 /

+0.09 (+1.94%)

06/21/21 Piper Sandler
Piper radar 'locked' on CymaBay EASL poster presentations on June 23
06/14/21 JonesTrading
JonesTrading starts CymaBay with Buy, $8 target on seladelpar potential
06/14/21 JonesTrading
CymaBay initiated with a Buy at JonesTrading
06/09/21 Piper Sandler
CymaBay to have 'impressive' lineup at EASL meeting, says Piper Sandler
PYPD PolyPid
$9.02 /

-0.19 (-2.06%)

11/24/20 Raymond James
Raymond James upgrades PolyPid to Strong Buy after BTD for D-PLEX
11/24/20 Raymond James
PolyPid upgraded to Strong Buy from Outperform at Raymond James
08/10/20 Alliance Global Partners
PolyPid initiated with a Buy at Alliance Global Partners
07/21/20 Raymond James
PolyPid initiated with an Outperform at Raymond James
AYLA Ayala Pharmaceuticals
$10.70 /

-0.13 (-1.20%)

12/07/20
Fly Intel: Top five analyst initiations
12/07/20 Roth Capital
Ayala Pharmaceuticals initiated with a Buy at Roth Capital
12/02/20
Fly Intel: Top five analyst initiations
12/02/20 Noble Capital
Ayala Pharmaceuticals initiated with an Outperform at Noble Capital
BWAY Brainsway
$10.40 /

-0.1 (-0.95%)

04/20/21 Northland
Brainsway initiated with an Outperform at Northland
02/17/21 Raymond James
Brainsway price target raised to $12 from $9 at Raymond James
ENTA Enanta
$46.24 /

+0.49 (+1.07%)

02/09/21 RBC Capital
Enanta price target raised to $53 from $47 at RBC Capital
01/29/21 JPMorgan
Enanta upgraded to Neutral with $55 target at JPMorgan
01/29/21 JPMorgan
Enanta upgraded to Neutral from Underweight at JPMorgan
01/08/21 Piper Sandler
Enanta remains 'significantly undervalued,' says Piper Sandler
KDMN Kadmon
$3.99 /

+0.01 (+0.25%)

06/04/21 Mizuho
Kadmon's KD022 results a positive start for immuno-oncology program, says Mizuho
05/20/21 UBS
Kadmon initiated with a Buy at UBS
03/11/21 Oppenheimer
Kadmon should be bought on weakness from FDA extension, says Oppenheimer
02/10/21 Jefferies
Survey points to 'encouraging' signs for Kadmon's belumosudil, says Jefferies
ONCS OncoSec
$3.40 /

-0.025 (-0.73%)

04/15/21 Alliance Global Partners
OncoSec price target raised to $11 from $6.50 at Alliance Global Partners
03/25/21 Maxim
OncoSec price target raised to $12 from $8 at Maxim
03/08/21
Fly Intel: Top five analyst initiations
03/08/21 BTIG
OncoSec initiated with a Buy at BTIG
ATHA Athira Pharma
$10.75 /

-0.31 (-2.80%)

06/18/21 Jefferies
Athira Pharma's 'unusual situation' to cause some volatility, says Jefferies
06/18/21 Stifel
Athira Pharma CEO leave situation 'impossible to really vet,' says Stifel
06/07/21 JMP Securities
Aducanumab accelerated approval positive for Athira, others, says JMP Securities
06/07/21 Goldman Sachs
Goldman says Biogen approval has positive read to Alector, Athira
QDEL Quidel
$111.86 /

-1.855 (-1.63%)

06/17/21 Craig-Hallum
Quidel price target lowered to $219 from $296 at Craig-Hallum
06/04/21 JPMorgan
Quidel price target lowered to $80 from $90 at JPMorgan
05/07/21 JPMorgan
Quidel price target lowered to $90 from $95 at JPMorgan
04/23/21 JPMorgan
Quidel price target lowered to $95 from $120 at JPMorgan
CYTK Cytokinetics
$21.77 /

+0.46 (+2.16%)

05/11/21 Mizuho
Cytokinetics price target raised to $36 from $26 at Mizuho
03/11/21 Wolfe Research
Cytokinetics initiated with an Outperform at Wolfe Research
02/18/21 Barclays
Cytokinetics initiated with an Overweight at Barclays
01/20/21 H.C. Wainwright
Cytokinetics price target raised to $41 from $22 at H.C. Wainwright
NGM NGM Biopharmaceuticals
$20.08 /

-0.26 (-1.28%)

05/25/21 B. Riley
NGM 'disappointing failure' in NASH a 'clearing event,' says B. Riley
05/25/21 BMO Capital
NGM Biopharmaceuticals price target lowered to $20 from $38 at BMO Capital
05/25/21 Raymond James
Raymond James downgrades two NASH players following NGM data
05/24/21 Piper Sandler
Piper says Madrigal's MAESTRO-NASH outcome not impacted by NGM ALPINE data
MEDXF Medexus Pharmaceuticals
$5.75 /

-0.2922 (-4.84%)

06/18/21 Canaccord
Medexus Pharmaceuticals price target lowered to C$9 from C$9.50 at Canaccord
03/03/21 Canaccord
Medexus Pharmaceuticals upgraded to Buy from Hold at Canaccord
02/24/21 Stifel
Medexus Pharmaceuticals price target raised to C$17.50 from C$7.25 at Stifel
FLXN Flexion
$9.14 /

+ (+0.00%)

04/26/21 Credit Suisse
Flexion assumed with an Outperform at Credit Suisse
04/14/21 Raymond James
Flexion price target lowered to $16 from $18 at Raymond James
04/06/21 RBC Capital
Flexion transferred with an Outperform at RBC Capital
08/20/20 Goldman Sachs
Flexion initiated with a Neutral at Goldman Sachs
HRMY Harmony Biosciences
$32.00 /

+0.68 (+2.17%)

03/29/21 Goldman Sachs
Harmony Biosciences upgraded to Buy from Neutral at Goldman Sachs
09/14/20 Jefferies
Harmony Biosciences initiated with a Buy at Jefferies
09/14/20 Piper Sandler
Harmony Biosciences initiated with an Overweight at Piper Sandler
09/13/20 Goldman Sachs
Harmony Biosciences initiated with a Neutral at Goldman Sachs
TFX Teleflex
$399.98 /

+3.115 (+0.78%)

QDEL Quidel
$111.86 /

-1.855 (-1.63%)

PYPD PolyPid
$9.02 /

-0.19 (-2.06%)

NGM NGM Biopharmaceuticals
$20.08 /

-0.26 (-1.28%)

HRMY Harmony Biosciences
$32.00 /

+0.68 (+2.17%)

FLXN Flexion
$9.14 /

+ (+0.00%)

ENTA Enanta
$46.24 /

+0.49 (+1.07%)

CYTK Cytokinetics
$21.77 /

+0.46 (+2.16%)

CBAY CymaBay
$4.74 /

+0.09 (+1.94%)

BWAY Brainsway
$10.40 /

-0.1 (-0.95%)

AYLA Ayala Pharmaceuticals
$10.70 /

-0.13 (-1.20%)

ATHA Athira Pharma
$10.75 /

-0.31 (-2.80%)

  • 23
    Feb
  • 21
    Jan
  • 21
    Jan
  • 06
    Jan
  • 18
    Sep
  • 19
    Aug
  • 17
    Jul
  • 26
    Jun
QDEL Quidel
$111.86 /

-1.855 (-1.63%)

QDEL Quidel
$111.86 /

-1.855 (-1.63%)

ONCS OncoSec
$3.40 /

-0.025 (-0.73%)

NGM NGM Biopharmaceuticals
$20.08 /

-0.26 (-1.28%)

KDMN Kadmon
$3.99 /

+0.01 (+0.25%)

FLXN Flexion
$9.14 /

+ (+0.00%)

ATHA Athira Pharma
$10.75 /

-0.31 (-2.80%)

ONCS OncoSec
$3.40 /

-0.025 (-0.73%)

ATHA Athira Pharma
$10.75 /

-0.31 (-2.80%)

Monday
Conference/Events
Raymond James to hold a virtual conference » 10:02
06/21/21
06/21
10:02
06/21/21
10:02
TFX

Teleflex

$394.92 /

-1.94 (-0.49%)

, CBAY

CymaBay

$4.71 /

+0.06 (+1.29%)

, PYPD

PolyPid

$9.20 /

-0.01 (-0.11%)

, AYLA

Ayala Pharmaceuticals

$10.83 /

+ (+0.00%)

, BWAY

Brainsway

$10.46 /

-0.04 (-0.38%)

, ENTA

Enanta

$45.88 /

+0.13 (+0.28%)

, KDMN

Kadmon

$4.00 /

+0.02 (+0.50%)

, ONCS

OncoSec

$3.39 /

-0.035 (-1.02%)

, ATHA

Athira Pharma

$11.35 /

+0.29 (+2.62%)

, QDEL

Quidel

$111.00 /

-2.715 (-2.39%)

, CYTK

Cytokinetics

$21.29 /

-0.02 (-0.09%)

, NGM

NGM Biopharmaceuticals

$20.00 /

-0.34 (-1.67%)

, MEDXF

Medexus Pharmaceuticals

$6.04 /

-0.1878 (-3.01%)

, FLXN

Flexion

$9.23 /

+0.09 (+0.98%)

, HRMY

Harmony Biosciences

$31.30 /

-0.02 (-0.06%)

Human Health Innovation…

Human Health Innovation Virtual Conference will be held on June 21-23.

ShowHide Related Items >><<
TFX Teleflex
$394.92 /

-1.94 (-0.49%)

QDEL Quidel
$111.00 /

-2.715 (-2.39%)

PYPD PolyPid
$9.20 /

-0.01 (-0.11%)

ONCS OncoSec
$3.39 /

-0.035 (-1.02%)

NGM NGM Biopharmaceuticals
$20.00 /

-0.34 (-1.67%)

MEDXF Medexus Pharmaceuticals
$6.04 /

-0.1878 (-3.01%)

KDMN Kadmon
$4.00 /

+0.02 (+0.50%)

HRMY Harmony Biosciences
$31.30 /

-0.02 (-0.06%)

FLXN Flexion
$9.23 /

+0.09 (+0.98%)

ENTA Enanta
$45.88 /

+0.13 (+0.28%)

CYTK Cytokinetics
$21.29 /

-0.02 (-0.09%)

CBAY CymaBay
$4.71 /

+0.06 (+1.29%)

BWAY Brainsway
$10.46 /

-0.04 (-0.38%)

AYLA Ayala Pharmaceuticals
$10.83 /

+ (+0.00%)

ATHA Athira Pharma
$11.35 /

+0.29 (+2.62%)

TFX Teleflex
$394.92 /

-1.94 (-0.49%)

05/18/21 Piper Sandler
Teleflex divestiture should accelerate sales growth, says Piper Sandler
05/10/21 Piper Sandler
Teleflex management surprised by post-earnings selloff, says Piper Sandler
04/30/21 SVB Leerink
Teleflex price target raised to $485 from $475 at SVB Leerink
02/25/21 Piper Sandler
Teleflex price target raised to $465 from $405 at Piper Sandler
CBAY CymaBay
$4.71 /

+0.06 (+1.29%)

06/14/21 JonesTrading
JonesTrading starts CymaBay with Buy, $8 target on seladelpar potential
06/14/21 JonesTrading
CymaBay initiated with a Buy at JonesTrading
06/09/21 Piper Sandler
CymaBay to have 'impressive' lineup at EASL meeting, says Piper Sandler
03/31/21 Cantor Fitzgerald
CymaBay price target lowered to $7 from $20 at Cantor Fitzgerald
PYPD PolyPid
$9.20 /

-0.01 (-0.11%)

11/24/20 Raymond James
Raymond James upgrades PolyPid to Strong Buy after BTD for D-PLEX
11/24/20 Raymond James
PolyPid upgraded to Strong Buy from Outperform at Raymond James
08/10/20 Alliance Global Partners
PolyPid initiated with a Buy at Alliance Global Partners
07/21/20 Raymond James
PolyPid initiated with an Outperform at Raymond James
AYLA Ayala Pharmaceuticals
$10.83 /

+ (+0.00%)

12/07/20
Fly Intel: Top five analyst initiations
12/07/20 Roth Capital
Ayala Pharmaceuticals initiated with a Buy at Roth Capital
12/02/20
Fly Intel: Top five analyst initiations
12/02/20 Noble Capital
Ayala Pharmaceuticals initiated with an Outperform at Noble Capital
BWAY Brainsway
$10.46 /

-0.04 (-0.38%)

04/20/21 Northland
Brainsway initiated with an Outperform at Northland
02/17/21 Raymond James
Brainsway price target raised to $12 from $9 at Raymond James
ENTA Enanta
$45.88 /

+0.13 (+0.28%)

02/09/21 RBC Capital
Enanta price target raised to $53 from $47 at RBC Capital
01/29/21 JPMorgan
Enanta upgraded to Neutral with $55 target at JPMorgan
01/29/21 JPMorgan
Enanta upgraded to Neutral from Underweight at JPMorgan
01/08/21 Piper Sandler
Enanta remains 'significantly undervalued,' says Piper Sandler
KDMN Kadmon
$4.00 /

+0.02 (+0.50%)

06/04/21 Mizuho
Kadmon's KD022 results a positive start for immuno-oncology program, says Mizuho
05/20/21 UBS
Kadmon initiated with a Buy at UBS
03/11/21 Oppenheimer
Kadmon should be bought on weakness from FDA extension, says Oppenheimer
02/10/21 Jefferies
Survey points to 'encouraging' signs for Kadmon's belumosudil, says Jefferies
ONCS OncoSec
$3.39 /

-0.035 (-1.02%)

04/15/21 Alliance Global Partners
OncoSec price target raised to $11 from $6.50 at Alliance Global Partners
03/25/21 Maxim
OncoSec price target raised to $12 from $8 at Maxim
03/08/21
Fly Intel: Top five analyst initiations
03/08/21 BTIG
OncoSec initiated with a Buy at BTIG
ATHA Athira Pharma
$11.35 /

+0.29 (+2.62%)

06/18/21 Jefferies
Athira Pharma's 'unusual situation' to cause some volatility, says Jefferies
06/18/21 Stifel
Athira Pharma CEO leave situation 'impossible to really vet,' says Stifel
06/07/21 JMP Securities
Aducanumab accelerated approval positive for Athira, others, says JMP Securities
06/07/21 Goldman Sachs
Goldman says Biogen approval has positive read to Alector, Athira
QDEL Quidel
$111.00 /

-2.715 (-2.39%)

06/17/21 Craig-Hallum
Quidel price target lowered to $219 from $296 at Craig-Hallum
06/04/21 JPMorgan
Quidel price target lowered to $80 from $90 at JPMorgan
05/07/21 JPMorgan
Quidel price target lowered to $90 from $95 at JPMorgan
04/23/21 JPMorgan
Quidel price target lowered to $95 from $120 at JPMorgan
CYTK Cytokinetics
$21.29 /

-0.02 (-0.09%)

05/11/21 Mizuho
Cytokinetics price target raised to $36 from $26 at Mizuho
03/11/21 Wolfe Research
Cytokinetics initiated with an Outperform at Wolfe Research
02/18/21 Barclays
Cytokinetics initiated with an Overweight at Barclays
01/20/21 H.C. Wainwright
Cytokinetics price target raised to $41 from $22 at H.C. Wainwright
NGM NGM Biopharmaceuticals
$20.00 /

-0.34 (-1.67%)

05/25/21 B. Riley
NGM 'disappointing failure' in NASH a 'clearing event,' says B. Riley
05/25/21 BMO Capital
NGM Biopharmaceuticals price target lowered to $20 from $38 at BMO Capital
05/25/21 Raymond James
Raymond James downgrades two NASH players following NGM data
05/24/21 Piper Sandler
Piper says Madrigal's MAESTRO-NASH outcome not impacted by NGM ALPINE data
MEDXF Medexus Pharmaceuticals
$6.04 /

-0.1878 (-3.01%)

06/18/21 Canaccord
Medexus Pharmaceuticals price target lowered to C$9 from C$9.50 at Canaccord
03/03/21 Canaccord
Medexus Pharmaceuticals upgraded to Buy from Hold at Canaccord
02/24/21 Stifel
Medexus Pharmaceuticals price target raised to C$17.50 from C$7.25 at Stifel
FLXN Flexion
$9.23 /

+0.09 (+0.98%)

04/26/21 Credit Suisse
Flexion assumed with an Outperform at Credit Suisse
04/14/21 Raymond James
Flexion price target lowered to $16 from $18 at Raymond James
04/06/21 RBC Capital
Flexion transferred with an Outperform at RBC Capital
08/20/20 Goldman Sachs
Flexion initiated with a Neutral at Goldman Sachs
HRMY Harmony Biosciences
$31.30 /

-0.02 (-0.06%)

03/29/21 Goldman Sachs
Harmony Biosciences upgraded to Buy from Neutral at Goldman Sachs
09/14/20 Jefferies
Harmony Biosciences initiated with a Buy at Jefferies
09/14/20 Piper Sandler
Harmony Biosciences initiated with an Overweight at Piper Sandler
09/13/20 Goldman Sachs
Harmony Biosciences initiated with a Neutral at Goldman Sachs
TFX Teleflex
$394.92 /

-1.94 (-0.49%)

QDEL Quidel
$111.00 /

-2.715 (-2.39%)

PYPD PolyPid
$9.20 /

-0.01 (-0.11%)

NGM NGM Biopharmaceuticals
$20.00 /

-0.34 (-1.67%)

HRMY Harmony Biosciences
$31.30 /

-0.02 (-0.06%)

FLXN Flexion
$9.23 /

+0.09 (+0.98%)

ENTA Enanta
$45.88 /

+0.13 (+0.28%)

CYTK Cytokinetics
$21.29 /

-0.02 (-0.09%)

CBAY CymaBay
$4.71 /

+0.06 (+1.29%)

BWAY Brainsway
$10.46 /

-0.04 (-0.38%)

AYLA Ayala Pharmaceuticals
$10.83 /

+ (+0.00%)

ATHA Athira Pharma
$11.35 /

+0.29 (+2.62%)

  • 23
    Feb
  • 21
    Jan
  • 21
    Jan
  • 06
    Jan
  • 18
    Sep
  • 19
    Aug
  • 17
    Jul
  • 26
    Jun
QDEL Quidel
$111.00 /

-2.715 (-2.39%)

QDEL Quidel
$111.00 /

-2.715 (-2.39%)

ONCS OncoSec
$3.39 /

-0.035 (-1.02%)

NGM NGM Biopharmaceuticals
$20.00 /

-0.34 (-1.67%)

KDMN Kadmon
$4.00 /

+0.02 (+0.50%)

FLXN Flexion
$9.23 /

+0.09 (+0.98%)

ATHA Athira Pharma
$11.35 /

+0.29 (+2.62%)

ONCS OncoSec
$3.39 /

-0.035 (-1.02%)

ATHA Athira Pharma
$11.35 /

+0.29 (+2.62%)

Over a week ago
Hot Stocks
Flexion announces William Andrews M.D as CMO effective July 1 » 16:23
06/09/21
06/09
16:23
06/09/21
16:23
FLXN

Flexion

$9.09 /

-0.06 (-0.66%)

Flexion Therapeutics…

Flexion Therapeutics announced that William T. Andrews, M.D., F.A.C.P., will join the company as Chief Medical Officer, CMO, effective July 1. "Will brings an impressive combination of medical, clinical, regulatory and corporate development skills, complemented by deep commercial experience he gained launching seven products throughout his career," said Michael Clayman, MD, President and Chief Executive Officer of Flexion Therapeutics. "He will play an integral role in building and strengthening our organization, and we could not be more excited to welcome him to our senior management team."

ShowHide Related Items >><<
FLXN Flexion
$9.09 /

-0.06 (-0.66%)

FLXN Flexion
$9.09 /

-0.06 (-0.66%)

04/26/21 Credit Suisse
Flexion assumed with an Outperform at Credit Suisse
04/14/21 Raymond James
Flexion price target lowered to $16 from $18 at Raymond James
04/06/21 RBC Capital
Flexion transferred with an Outperform at RBC Capital
08/20/20 Goldman Sachs
Flexion initiated with a Neutral at Goldman Sachs
FLXN Flexion
$9.09 /

-0.06 (-0.66%)

FLXN Flexion
$9.09 /

-0.06 (-0.66%)

Over a month ago
On The Fly
Fly Intel: After-Hours Movers » 20:45
05/12/21
05/12
20:45
05/12/21
20:45
FTEK

Fuel Tech

$1.94 /

+0.025 (+1.31%)

, SONO

Sonos

$31.46 /

-3.42 (-9.81%)

, VRM

Vroom

$35.44 /

-1.4 (-3.80%)

, BOOT

Boot Barn

$67.50 /

-4.96 (-6.85%)

, ONTF

On24

$36.78 /

-1.975 (-5.10%)

, SFT

Shift

$7.43 /

-0.37 (-4.74%)

, RNA

Avidity Biosciences

$23.30 /

+0.85 (+3.79%)

, QGEN

Qiagen

$46.26 /

-0.125 (-0.27%)

, WISH

ContextLogic

$11.49 /

-0.255 (-2.17%)

, POSH

Poshmark

$43.76 /

-0.35 (-0.79%)

, YCBD

cbdMD

$3.48 /

+0.05 (+1.46%)

, TDUP

ThredUP

$19.95 /

+0.66 (+3.42%)

, ONEM

1Life Healthcare

$38.27 /

-0.49 (-1.26%)

, ZVO

Zovio

$3.47 /

+0.14 (+4.20%)

, FLR

Fluor

$23.79 /

-0.62 (-2.54%)

, FLXN

Flexion

$7.51 /

+0.25 (+3.44%)

, JACK

Jack in the Box

$117.00 /

-5.41 (-4.42%)

, APP

AppLovin

$52.11 /

-1.2 (-2.25%)

, COIN

Coinbase

$283.50 /

-19.35 (-6.39%)

, TSLA

Tesla

$590.12 /

-26.78 (-4.34%)

, MARA

Marathon Digital

$22.85 /

-3.08 (-11.88%)

, RIOT

Riot Blockchain

$26.47 /

-3.37 (-11.29%)

, BTC

Bitcoin

/

+

, $BTC

Bitcoin

/

+

Check out this evening's…

ShowHide Related Items >><<
ZVO Zovio
$3.47 /

+0.14 (+4.20%)

YCBD cbdMD
$3.48 /

+0.05 (+1.46%)

WISH ContextLogic
$11.49 /

-0.255 (-2.17%)

VRM Vroom
$35.44 /

-1.4 (-3.80%)

TSLA Tesla
$590.12 /

-26.78 (-4.34%)

SONO Sonos
$31.46 /

-3.42 (-9.81%)

SFT Shift
$7.43 /

-0.37 (-4.74%)

RNA Avidity Biosciences
$23.30 /

+0.85 (+3.79%)

RIOT Riot Blockchain
$26.47 /

-3.37 (-11.29%)

QGEN Qiagen
$46.26 /

-0.125 (-0.27%)

POSH Poshmark
$43.76 /

-0.35 (-0.79%)

ONEM 1Life Healthcare
$38.27 /

-0.49 (-1.26%)

MARA Marathon Digital
$22.85 /

-3.08 (-11.88%)

JACK Jack in the Box
$117.00 /

-5.41 (-4.42%)

FTEK Fuel Tech
$1.94 /

+0.025 (+1.31%)

FLXN Flexion
$7.51 /

+0.25 (+3.44%)

FLR Fluor
$23.79 /

-0.62 (-2.54%)

COIN Coinbase
$283.50 /

-19.35 (-6.39%)

BTC Bitcoin
/

+

BOOT Boot Barn
$67.50 /

-4.96 (-6.85%)

FTEK Fuel Tech
$1.94 /

+0.025 (+1.31%)

SONO Sonos
$31.46 /

-3.42 (-9.81%)

03/10/21 Stifel
Sonos price target raised to $40 from $34 at Stifel
03/05/21 Morgan Stanley
Sonos analyst day to be positive catalyst for shares, says Morgan Stanley
02/11/21 Goldman Sachs
Sonos upgraded to Neutral from Sell at Goldman Sachs
02/11/21 Morgan Stanley
Sonos price target raised to $45 from $35 at Morgan Stanley
VRM Vroom
$35.44 /

-1.4 (-3.80%)

04/13/21 Wedbush
Vroom added to Best List Ideas at Wedbush
04/07/21 Raymond James
Raymond James starts Vroom at Outperform on digital auto secular growth
04/07/21 Raymond James
Vroom initiated with an Outperform at Raymond James
03/04/21 Truist
Vroom price target lowered to $54 from $58 at Truist
BOOT Boot Barn
$67.50 /

-4.96 (-6.85%)

02/10/21 Cowen
Boot Barn price target raised to $68 from $65 at Cowen
01/26/21 Jefferies
Boot Barn price target raised to $72 from $68 at Jefferies
01/26/21 Craig-Hallum
Boot Barn price target raised to $54 from $48 at Craig-Hallum
01/26/21 William Blair
Boot Barn valuation remains 'compelling,' says William Blair
ONTF On24
$36.78 /

-1.975 (-5.10%)

04/29/21 KeyBanc
On24 price target lowered to $65 from $73 at KeyBanc
03/02/21 Baird
Baird remains bullish on On24 after listening to customers
03/01/21 Canaccord
On24 initiated with a Buy at Canaccord
03/01/21 KeyBanc
On24 initiated with an Overweight at KeyBanc
SFT Shift
$7.43 /

-0.37 (-4.74%)

05/04/21 Wedbush
Shift upgraded to Neutral from Underperform at Wedbush
03/09/21 Benchmark
Benchmark sees Shift on a 'positive path,' upgrades to Buy
03/09/21 Benchmark
Shift upgraded to Buy from Hold at Benchmark
01/25/21 DA Davidson
Shift initiated with a Buy at DA Davidson
RNA Avidity Biosciences
$23.30 /

+0.85 (+3.79%)

04/26/21 Credit Suisse
Avidity Biosciences assumed with an Outperform at Credit Suisse
07/07/20 Cowen
Avidity Biosciences initiated with an Outperform at Cowen
07/07/20 SVB Leerink
Avidity Biosciences initiated with an Outperform at SVB Leerink
07/07/20 Cowen
Avidity Biosciences initiated with an Outperform at Cowen
QGEN Qiagen
$46.26 /

-0.125 (-0.27%)

02/19/21 Berenberg
Qiagen price target raised to EUR 56 from EUR 52 at Berenberg
02/09/21 William Blair
Quidel, Qiagen merger would not make sense, says William Blair
02/09/21 Wells Fargo
Qiagen shares should be sold on latest merger talk, says Wells Fargo
02/09/21 Citi
Merger with Qiagen would benefit Quidel, says Citi
WISH ContextLogic
$11.49 /

-0.255 (-2.17%)

04/05/21 Evercore ISI
ContextLogic initiated with an Outperform at Evercore ISI
03/30/21 Loop Capital
ContextLogic to 'lap' easy comparisons in Q1, says Loop Capital
03/18/21 JPMorgan
ContextLogic shares attractive at current levels, says JPMorgan
03/09/21 Stifel
ContextLogic price target lowered to $20 from $22 at Stifel
POSH Poshmark
$43.76 /

-0.35 (-0.79%)

03/12/21 MKM Partners
Poshmark price target lowered to $83 from $88 at MKM Partners
03/12/21 Raymond James
Poshmark price target lowered to $68 from $83 at Raymond James
03/12/21 Cowen
Poshmark price target lowered to $70 from $88 at Cowen
02/22/21 Evercore ISI
Evercore upgrades Foot Locker to Outperform on 'cemented' sneaker position
YCBD cbdMD
$3.48 /

+0.05 (+1.46%)

TDUP ThredUP
$19.95 /

+0.66 (+3.42%)

04/20/21 William Blair
ThredUP initiated with an Outperform at William Blair
04/20/21 Wells Fargo
ThredUP initiated with an Overweight at Wells Fargo
04/20/21 Piper Sandler
ThredUP initiated with an Overweight at Piper Sandler
04/20/21 Telsey Advisory
ThredUP initiated with an Outperform at Telsey Advisory
ONEM 1Life Healthcare
$38.27 /

-0.49 (-1.26%)

05/03/21 Jefferies
Jefferies confident in path to 'much larger' 1Life Healthcare, starts at Buy
05/03/21 Jefferies
1Life Healthcare initiated with a Buy at Jefferies
04/26/21 Piper Sandler
Piper Sandler 'incrementally bullish' on Amwell, Teladoc, 1Life
04/08/21 Piper Sandler
1Life app downloads suggest Q1 beat, says Piper Sandler
ZVO Zovio
$3.47 /

+0.14 (+4.20%)

04/09/21
Fly Intel: Top five analyst initiations
04/09/21 Northland
Zovio initiated with an Outperform at Northland
01/06/21 Barrington
Imax and Sirius XM among Barrington's best ideas for 2021
08/03/20 Barrington
Zovio price target raised to $10 from $8 at Barrington
FLR Fluor
$23.79 /

-0.62 (-2.54%)

05/10/21 Barclays
Fluor price target raised to $27 from $22 at Barclays
04/21/21 Citi
Fluor price target raised to $23 from $18 at Citi
03/01/21 Citi
Fluor price target lowered to $18 from $22 at Citi
01/21/21 Vertical Research
Fluor upgraded to Buy on turnaround plan at Vertical Research
FLXN Flexion
$7.51 /

+0.25 (+3.44%)

04/26/21 Credit Suisse
Flexion assumed with an Outperform at Credit Suisse
04/14/21 Raymond James
Flexion price target lowered to $16 from $18 at Raymond James
04/06/21 RBC Capital
Flexion transferred with an Outperform at RBC Capital
08/20/20 Goldman Sachs
Flexion initiated with a Neutral at Goldman Sachs
JACK Jack in the Box
$117.00 /

-5.41 (-4.42%)

05/10/21 Cowen
Jack in the Box price target raised to $140 from $120 at Cowen
05/06/21 Wells Fargo
Jack in the Box price target raised to $146 from $124 at Wells Fargo
04/27/21 Oppenheimer
Jack in the Box price target raised to $135 from $115 at Oppenheimer
04/21/21
Fly Intel: Top five analyst downgrades
APP AppLovin
$52.11 /

-1.2 (-2.25%)

05/10/21
Fly Intel: Top five analyst initiations
05/10/21 Stifel
AppLovin initiated with a Hold at Stifel
05/10/21 UBS
AppLovin initiated with a Buy at UBS
05/10/21 Truist
AppLovin initiated with a Buy at Truist
COIN Coinbase
$283.50 /

-19.35 (-6.39%)

05/10/21 Oppenheimer
Oppenheimer starts Coinbase at Outperform with $434 price target
05/10/21 Oppenheimer
Coinbase initiated with an Outperform at Oppenheimer
05/04/21
Fly Intel: Top five analyst initiations
05/04/21 Mizuho
Coinbase price target raised to $315 from $285 at Mizuho
TSLA Tesla
$590.12 /

-26.78 (-4.34%)

05/12/21 JPMorgan
JPMorgan says reports on Tesla halting Shanghai expansion are inaccurate
05/11/21 Piper Sandler
Piper says 'hard to draw meaningful conclusions' from 'messy' Tesla China data
05/11/21 Wedbush
Tesla April China deliveries see some softness, China tensions key, says Wedbush
05/10/21 Wedbush
Tesla demand looks robust so far in Q2 despite rising competition, says Wedbush
MARA Marathon Digital
$22.85 /

-3.08 (-11.88%)

03/17/21 H.C. Wainwright
Marathon Digital price target raised to $50 from $30 at H.C. Wainwright
02/08/21 H.C. Wainwright
Marathon Patent Group price target raised to $30 from $17 at H.C. Wainwright
11/23/20 H.C. Wainwright
Marathon Patent Group initiated with a Buy at H.C. Wainwright
RIOT Riot Blockchain
$26.47 /

-3.37 (-11.29%)

11/23/20 H.C. Wainwright
Riot Blockchain price target raised to $7.50 from $3.50 at H.C. Wainwright
BTC Bitcoin
/

+

04/27/21 Roth Capital
Regulatory credits, bitcoin fuel Tesla Q1 headline beat, says Roth Capital
04/15/21 Morgan Stanley
WisdomTree Bitcoin ETP cross-listing could speed up growth, says Morgan Stanley
01/13/21 Standpoint Research
Bitcoin could hit $112,000 this year, says Standpoint Research
$BTC Bitcoin
/

+

ZVO Zovio
$3.47 /

+0.14 (+4.20%)

YCBD cbdMD
$3.48 /

+0.05 (+1.46%)

WISH ContextLogic
$11.49 /

-0.255 (-2.17%)

VRM Vroom
$35.44 /

-1.4 (-3.80%)

TSLA Tesla
$590.12 /

-26.78 (-4.34%)

TDUP ThredUP
$19.95 /

+0.66 (+3.42%)

SONO Sonos
$31.46 /

-3.42 (-9.81%)

SFT Shift
$7.43 /

-0.37 (-4.74%)

RNA Avidity Biosciences
$23.30 /

+0.85 (+3.79%)

RIOT Riot Blockchain
$26.47 /

-3.37 (-11.29%)

QGEN Qiagen
$46.26 /

-0.125 (-0.27%)

POSH Poshmark
$43.76 /

-0.35 (-0.79%)

ONTF On24
$36.78 /

-1.975 (-5.10%)

ONEM 1Life Healthcare
$38.27 /

-0.49 (-1.26%)

MARA Marathon Digital
$22.85 /

-3.08 (-11.88%)

JACK Jack in the Box
$117.00 /

-5.41 (-4.42%)

FTEK Fuel Tech
$1.94 /

+0.025 (+1.31%)

FLXN Flexion
$7.51 /

+0.25 (+3.44%)

FLR Fluor
$23.79 /

-0.62 (-2.54%)

COIN Coinbase
$283.50 /

-19.35 (-6.39%)

BTC Bitcoin
/

+

BOOT Boot Barn
$67.50 /

-4.96 (-6.85%)

APP AppLovin
$52.11 /

-1.2 (-2.25%)

  • 14
    Apr
  • 15
    Apr
  • 26
    Mar
  • 10
    Feb
  • 03
    Feb
  • 14
    Jan
  • 16
    Dec
  • 07
    Dec
  • 23
    Nov
  • 11
    Sep
  • 24
    Jul
  • 25
    Jun
  • 18
    Jun
  • 12
    Jun
  • 09
    Jun
  • 21
    May
WISH ContextLogic
$11.49 /

-0.255 (-2.17%)

VRM Vroom
$35.44 /

-1.4 (-3.80%)

TSLA Tesla
$590.12 /

-26.78 (-4.34%)

SONO Sonos
$31.46 /

-3.42 (-9.81%)

RIOT Riot Blockchain
$26.47 /

-3.37 (-11.29%)

QGEN Qiagen
$46.26 /

-0.125 (-0.27%)

ONEM 1Life Healthcare
$38.27 /

-0.49 (-1.26%)

COIN Coinbase
$283.50 /

-19.35 (-6.39%)

BTC Bitcoin
/

+

ZVO Zovio
$3.47 /

+0.14 (+4.20%)

YCBD cbdMD
$3.48 /

+0.05 (+1.46%)

WISH ContextLogic
$11.49 /

-0.255 (-2.17%)

VRM Vroom
$35.44 /

-1.4 (-3.80%)

TSLA Tesla
$590.12 /

-26.78 (-4.34%)

TDUP ThredUP
$19.95 /

+0.66 (+3.42%)

SONO Sonos
$31.46 /

-3.42 (-9.81%)

SFT Shift
$7.43 /

-0.37 (-4.74%)

RIOT Riot Blockchain
$26.47 /

-3.37 (-11.29%)

QGEN Qiagen
$46.26 /

-0.125 (-0.27%)

POSH Poshmark
$43.76 /

-0.35 (-0.79%)

ONTF On24
$36.78 /

-1.975 (-5.10%)

ONEM 1Life Healthcare
$38.27 /

-0.49 (-1.26%)

MARA Marathon Digital
$22.85 /

-3.08 (-11.88%)

JACK Jack in the Box
$117.00 /

-5.41 (-4.42%)

FLXN Flexion
$7.51 /

+0.25 (+3.44%)

FLR Fluor
$23.79 /

-0.62 (-2.54%)

COIN Coinbase
$283.50 /

-19.35 (-6.39%)

BTC Bitcoin
/

+

BOOT Boot Barn
$67.50 /

-4.96 (-6.85%)

APP AppLovin
$52.11 /

-1.2 (-2.25%)

YCBD cbdMD
$3.48 /

+0.05 (+1.46%)

WISH ContextLogic
$11.49 /

-0.255 (-2.17%)

VRM Vroom
$35.44 /

-1.4 (-3.80%)

TSLA Tesla
$590.12 /

-26.78 (-4.34%)

TDUP ThredUP
$19.95 /

+0.66 (+3.42%)

SONO Sonos
$31.46 /

-3.42 (-9.81%)

SFT Shift
$7.43 /

-0.37 (-4.74%)

RIOT Riot Blockchain
$26.47 /

-3.37 (-11.29%)

POSH Poshmark
$43.76 /

-0.35 (-0.79%)

MARA Marathon Digital
$22.85 /

-3.08 (-11.88%)

FTEK Fuel Tech
$1.94 /

+0.025 (+1.31%)

FLR Fluor
$23.79 /

-0.62 (-2.54%)

COIN Coinbase
$283.50 /

-19.35 (-6.39%)

BOOT Boot Barn
$67.50 /

-4.96 (-6.85%)

APP AppLovin
$52.11 /

-1.2 (-2.25%)

Earnings
Flexion reports Q1 EPS (57c), consensus (52c) » 16:08
05/12/21
05/12
16:08
05/12/21
16:08
FLXN

Flexion

$7.50 /

+0.24 (+3.31%)

Reports Q1 revenue…

Reports Q1 revenue $24.59M, consensus $24.77M. "The first quarter of 2021 was marked by solid ZILRETTA sales and important progress with both FX201 and FX301, our exciting investigational drug candidates," said Michael Clayman, president and CEO. "While COVID-19 continues to weigh on the nation, broad availability of vaccines and dropping infection rates, combined with our laser-like focus on commercial execution, reinforce our confidence in our ability to deliver full-year net sales in the range of $120 million to $130 million."

ShowHide Related Items >><<
FLXN Flexion
$7.50 /

+0.24 (+3.31%)

FLXN Flexion
$7.50 /

+0.24 (+3.31%)

04/26/21 Credit Suisse
Flexion assumed with an Outperform at Credit Suisse
04/14/21 Raymond James
Flexion price target lowered to $16 from $18 at Raymond James
04/06/21 RBC Capital
Flexion transferred with an Outperform at RBC Capital
08/20/20 Goldman Sachs
Flexion initiated with a Neutral at Goldman Sachs
FLXN Flexion
$7.50 /

+0.24 (+3.31%)

  • 21
    May
FLXN Flexion
$7.50 /

+0.24 (+3.31%)

Hot Stocks
Flexion presents preliminary FX201 clinical data at ASGCT meeting » 07:42
04/28/21
04/28
07:42
04/28/21
07:42
FLXN

Flexion

$8.58 /

-0.05 (-0.58%)

Flexion Therapeutics will…

Flexion Therapeutics will present preliminary data from a Phase 1 single ascending dose trial of FX201 at the 2021 American Society of Gene & Cell Therapy annual meeting taking place virtually May 11-14, 2021 The clinical data will be presented in a digital presentation entitled, Interim Data from the First-in-Human Phase 1 Trial of FX201, An Intra-Articular, Helper-Dependent Adenoviral Gene Therapy for Osteoarthritis - Safety, Tolerability, Biodistribution, and Preliminary Evaluation of Clinical Activity in 5 Patients. Key findings included in the ASCGT abstract: FX201 was generally well-tolerated in the initial low-dose cohort. Two patients had self-limited Grade 2 index-knee AEs possibly related to treatment, managed conservatively. No evidence of systemic biodistribution of FX201 in plasma or shedding in urine or at the injection site was observed in any patient, indicating that the vector remained in the encapsulated joint space. Based on IMMPACT1 criteria, two out of the five patients demonstrated substantial improvement in knee OA pain at Weeks 8, 12, and 24 following treatment with FX201. Flexion will present longer term follow-up data from the low-dose cohort in a video presentation available on the ASGCT website at the start of the conference on May 11.

ShowHide Related Items >><<
FLXN Flexion
$8.58 /

-0.05 (-0.58%)

FLXN Flexion
$8.58 /

-0.05 (-0.58%)

04/26/21 Credit Suisse
Flexion assumed with an Outperform at Credit Suisse
04/14/21 Raymond James
Flexion price target lowered to $16 from $18 at Raymond James
04/06/21 RBC Capital
Flexion transferred with an Outperform at RBC Capital
08/20/20 Goldman Sachs
Flexion initiated with a Neutral at Goldman Sachs
FLXN Flexion
$8.58 /

-0.05 (-0.58%)

  • 21
    May
FLXN Flexion
$8.58 /

-0.05 (-0.58%)

Initiation
Flexion assumed with an Outperform at Credit Suisse » 06:39
04/26/21
04/26
06:39
04/26/21
06:39
FLXN

Flexion

$8.17 /

-0.06 (-0.73%)

Credit Suisse analyst…

Credit Suisse analyst Judah Frommer assumed coverage of Flexion with an unchanged Outperform rating and $17 price target.

ShowHide Related Items >><<
FLXN Flexion
$8.17 /

-0.06 (-0.73%)

FLXN Flexion
$8.17 /

-0.06 (-0.73%)

04/14/21 Raymond James
Flexion price target lowered to $16 from $18 at Raymond James
04/06/21 RBC Capital
Flexion transferred with an Outperform at RBC Capital
08/20/20 Goldman Sachs
Flexion initiated with a Neutral at Goldman Sachs
07/30/20 Oppenheimer
Flexion initiated with an Outperform at Oppenheimer
FLXN Flexion
$8.17 /

-0.06 (-0.73%)

  • 21
    May
FLXN Flexion
$8.17 /

-0.06 (-0.73%)

Recommendations
Flexion price target lowered to $16 from $18 at Raymond James » 07:09
04/14/21
04/14
07:09
04/14/21
07:09
FLXN

Flexion

$9.37 /

+1.05 (+12.62%)

Raymond James analyst…

Raymond James analyst Elliot Wilbur lowered the firm's price target on Flexion to $16 from $18 and keeps a Strong Buy rating on the shares. Flexion announced a preliminary 1Q21 sales number of $24.6M, which is relatively in line with external expectations, reaffirming the recovery trajectory of Zilretta despite continued pressure from the ongoing pandemic, Wilbur tells investors in a research note.

ShowHide Related Items >><<
FLXN Flexion
$9.37 /

+1.05 (+12.62%)

FLXN Flexion
$9.37 /

+1.05 (+12.62%)

04/06/21 RBC Capital
Flexion transferred with an Outperform at RBC Capital
08/20/20 Goldman Sachs
Flexion initiated with a Neutral at Goldman Sachs
07/30/20 Oppenheimer
Flexion initiated with an Outperform at Oppenheimer
07/29/20
Fly Intel: Top five analyst initiations
FLXN Flexion
$9.37 /

+1.05 (+12.62%)

  • 21
    May
FLXN Flexion
$9.37 /

+1.05 (+12.62%)

On The Fly
Fly Intel: After-Hours Movers » 18:19
04/13/21
04/13
18:19
04/13/21
18:19
SAP

SAP

$134.51 /

+2.08 (+1.57%)

, FLXN

Flexion

$9.37 /

+1.05 (+12.62%)

, BRKR

Bruker

$68.97 /

+1.43 (+2.12%)

, TEAM

Atlassian

$242.24 /

+11.72 (+5.08%)

, PKI

PerkinElmer

$135.39 /

+2.695 (+2.03%)

, MRNA

Moderna

$149.63 /

+10.34 (+7.42%)

, SEAC

SeaChange

$1.38 /

-0.095 (-6.46%)

, SFIX

Stitch Fix

$49.46 /

-1.3 (-2.56%)

, STSA

Satsuma Pharmaceuticals

$5.44 /

+0.37 (+7.30%)

Check out this evening's…

ShowHide Related Items >><<
TEAM Atlassian
$242.24 /

+11.72 (+5.08%)

STSA Satsuma Pharmaceuticals
$5.44 /

+0.37 (+7.30%)

SFIX Stitch Fix
$49.46 /

-1.3 (-2.56%)

SEAC SeaChange
$1.38 /

-0.095 (-6.46%)

SAP SAP
$134.51 /

+2.08 (+1.57%)

PKI PerkinElmer
$135.39 /

+2.695 (+2.03%)

MRNA Moderna
$149.63 /

+10.34 (+7.42%)

FLXN Flexion
$9.37 /

+1.05 (+12.62%)

BRKR Bruker
$68.97 /

+1.43 (+2.12%)

SAP SAP
$134.51 /

+2.08 (+1.57%)

04/09/21 Societe Generale
SAP price target lowered to EUR 136 from EUR 138 at Societe Generale
03/25/21 Credit Suisse
SAP assumed with an Outperform at Credit Suisse
03/12/21 JMP Securities
Domo price target raised to $89 from $80 at JMP Securities
03/10/21 Craig-Hallum
Talend go-shop 'could spark interest,' says Craig-Hallum
FLXN Flexion
$9.37 /

+1.05 (+12.62%)

04/06/21 RBC Capital
Flexion transferred with an Outperform at RBC Capital
08/20/20 Goldman Sachs
Flexion initiated with a Neutral at Goldman Sachs
07/30/20 Oppenheimer
Flexion initiated with an Outperform at Oppenheimer
07/29/20
Fly Intel: Top five analyst initiations
BRKR Bruker
$68.97 /

+1.43 (+2.12%)

02/17/21 Stifel
Bruker price target raised to $65 from $48 at Stifel
02/17/21 Citi
Bruker price target raised to $65 from $57 at Citi
02/05/21 Wells Fargo
Bruker downgraded to Equal Weight with $55 target at Wells Fargo
02/05/21 Wells Fargo
Bruker downgraded to Equal Weight from Overweight at Wells Fargo
TEAM Atlassian
$242.24 /

+11.72 (+5.08%)

03/08/21 Morgan Stanley
Software industry rating raised to Attractive from In-Line at Morgan Stanley
03/03/21 Citi
Atlassian assumed with a Buy at Citi
01/29/21 DA Davidson
Atlassian price target raised to $275 from $235 at DA Davidson
01/29/21 BMO Capital
Atlassian price target raised to $260 from $235 at BMO Capital
PKI PerkinElmer
$135.39 /

+2.695 (+2.03%)

02/03/21 Citi
PerkinElmer price target raised to $155 from $150 at Citi
01/07/21 Piper Sandler
Oxford Immunotec downgraded to Neutral from Overweight at Piper Sandler
01/07/21 Wells Fargo
PerkinElmer upgraded to Overweight from Equal Weight at Wells Fargo
01/07/21 Wells Fargo
PerkinElmer upgraded to Overweight from Equal Weight at Wells Fargo
MRNA Moderna
$149.63 /

+10.34 (+7.42%)

04/13/21 Morgan Stanley
Morgan Stanley says J&J news could improve 2022 outlook for mRNA vaccine makers
04/13/21 Piper Sandler
Piper reiterates $208 target on Moderna after J&J Covid vaccine pause
04/07/21 Jefferies
Catalent pact with Moderna removes potential overhang, says Jefferies
03/15/21 Piper Sandler
Piper Sandler bullish on Moderna as first subject vaccinated in '1283 study
SEAC SeaChange
$1.38 /

-0.095 (-6.46%)

09/09/20 Lake Street
SeaChange price target lowered to $2 from $4 at Lake Street
SFIX Stitch Fix
$49.46 /

-1.3 (-2.56%)

04/05/21 Evercore ISI
Stitch Fix initiated with an Outperform at Evercore ISI
03/09/21
Fly Intel: Top five analyst downgrades
03/09/21 Canaccord
Stitch Fix price target lowered to $68 from $72 at Canaccord
03/09/21 KeyBanc
Stitch Fix price target lowered to $75 from $95 at KeyBanc
STSA Satsuma Pharmaceuticals
$5.44 /

+0.37 (+7.30%)

04/05/21 Mizuho
Satsuma Pharmaceuticals price target raised to $7 from $3.50 at Mizuho
03/02/21 Credit Suisse
Satsuma Pharmaceuticals upgraded to Neutral from Underperform at Credit Suisse
03/02/21 Credit Suisse
Satsuma upgraded to Neutral from Underperform at Credit Suisse
11/11/20 Mizuho
Satsuma Pharmaceuticals price target lowered to $3.50 from $4 at Mizuho
TEAM Atlassian
$242.24 /

+11.72 (+5.08%)

STSA Satsuma Pharmaceuticals
$5.44 /

+0.37 (+7.30%)

SFIX Stitch Fix
$49.46 /

-1.3 (-2.56%)

SEAC SeaChange
$1.38 /

-0.095 (-6.46%)

SAP SAP
$134.51 /

+2.08 (+1.57%)

PKI PerkinElmer
$135.39 /

+2.695 (+2.03%)

MRNA Moderna
$149.63 /

+10.34 (+7.42%)

FLXN Flexion
$9.37 /

+1.05 (+12.62%)

BRKR Bruker
$68.97 /

+1.43 (+2.12%)

  • 30
    Mar
  • 21
    Oct
  • 21
    May
  • 19
    May
SAP SAP
$134.51 /

+2.08 (+1.57%)

MRNA Moderna
$149.63 /

+10.34 (+7.42%)

TEAM Atlassian
$242.24 /

+11.72 (+5.08%)

SFIX Stitch Fix
$49.46 /

-1.3 (-2.56%)

SEAC SeaChange
$1.38 /

-0.095 (-6.46%)

SAP SAP
$134.51 /

+2.08 (+1.57%)

PKI PerkinElmer
$135.39 /

+2.695 (+2.03%)

MRNA Moderna
$149.63 /

+10.34 (+7.42%)

BRKR Bruker
$68.97 /

+1.43 (+2.12%)

TEAM Atlassian
$242.24 /

+11.72 (+5.08%)

STSA Satsuma Pharmaceuticals
$5.44 /

+0.37 (+7.30%)

SFIX Stitch Fix
$49.46 /

-1.3 (-2.56%)

SEAC SeaChange
$1.38 /

-0.095 (-6.46%)

SAP SAP
$134.51 /

+2.08 (+1.57%)

MRNA Moderna
$149.63 /

+10.34 (+7.42%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.